Access Statistics for Matthew J. Higgins

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Country‑Specific View of Tariffs 0 0 14 14 0 3 26 26
Accounting for Price Endogeneity in Airline Itinerary Choice Models: An Application to Continental U.S. Markets 0 0 0 46 0 4 15 99
Assets with "Warts": How Reliable is the Market for Technology? 0 0 0 8 0 2 4 42
Behind the Scenes: Sources of Complementarity in R&D 0 0 0 16 0 4 13 89
Black Populations and Economic Growth: An Extreme Bounds Analysis of Mississippi County-Level Data 0 0 0 37 1 2 12 270
Blockbusters, Sequels and the Nature of Innovation 0 0 14 14 0 3 37 37
Conveying Quality and Value in Emerging Industries: Star Scientists and the Role of Learning in Biotechnology 0 0 0 34 1 3 12 233
Corporate Venture Capital as a Real Option in the Markets for Technology 0 0 1 72 0 4 14 115
Don’t Throw the Baby Out With the Bathwater: Firm Response to Downstream Product Shocks 0 0 1 18 0 3 14 38
Explaining Preferences for Control Rights in Strategic Alliances: A Property Rights and Capabilities Perspective Approach 0 0 0 29 0 2 12 89
Federal, State, and Local Governments: Evaluating their Separate Roles in US Growth 0 0 0 61 1 4 16 439
Federal, State, and Local Governments: Evaluating their Separate Roles in US Growth 0 0 0 47 0 0 11 376
Federal, State, and Local Governments:Evaluating their Separate Roles in US Growth 0 0 0 12 0 1 11 153
Federal, state, and local governments: evaluating their separate roles in US growth 0 0 0 4 0 0 16 52
Generic Competition and the Incentives for Early-Stage Pharmaceutical Innovation 0 0 2 42 1 3 24 123
Growth and Convergence across the U.S: Evidence from County-Level Data 0 0 0 255 2 4 29 791
Growth and Convergence across the US: Evidence from County-Level Data 0 0 0 7 0 3 20 117
Growth and Convergence across the US: Evidence from County-Level Data 0 0 0 204 0 2 23 644
Growth and Convergence across the US: Evidence from County-Level Data 0 0 0 15 1 3 14 188
Growth and Convergence across the United States: Evidence from County-Level Data 0 0 0 2 0 2 13 34
Heterogeneity in Convergence Rates and Income Determination across U.S. States: Evidence from County-Level Data 0 0 0 209 0 2 9 1,138
Heterogeneity in Convergence Rates and Income Determination across U.S. States: Evidence from County-Level Data 0 0 0 2 0 0 8 106
Heterogeneous Convergence 0 0 0 15 0 2 21 114
Heterogeneous Convergence 0 0 0 39 0 1 16 350
Heterogeneous Convergence 0 0 0 14 0 6 25 118
Heterogeneous Convergence 0 0 0 57 0 1 13 217
Heterogeneous convergence 0 0 0 2 0 1 13 42
Intra-alliance performance, control rights, and today's split of tomorrow's value 0 0 0 85 0 0 9 235
Many Types of Human Capital and Many Roles in U.S. Growth: Evidence from County-Level Educational Attainment Data 0 0 0 426 1 4 18 3,829
Many Types of Human Capital and Many Roles in U.S. Growth: Evidence from County-Level Educational Attainment Data 0 0 0 11 0 0 8 128
Market Size and Research: Evidence from the Pharmaceutical Industry 1 1 1 18 2 5 10 64
Moving Beyond the Valley of Death: Regulation and Venture Capital Investments in Early-Stage Biopharmaceutical Firms 1 1 2 44 2 5 15 76
Pediatric Drug Adherence and Parental Attention: Evidence from Comprehensive Claims Data 0 0 0 1 0 2 7 19
Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry 0 0 1 58 1 5 19 288
Research and Market Structure: Evidence from an Antibiotic-Resistant Pathogenic Outbreak 0 0 0 2 0 4 14 30
Robust Correlates of County-Level Growth in the U.S 0 0 1 40 1 2 15 188
Robust correlates of county-level growth in the United States 0 0 0 0 0 1 7 19
Sigma Convergence Versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 0 30 1 2 12 138
Sigma Convergence Versus Beta Convergence: Evidence from U.S. County-Level Data (revised version) 0 1 1 37 0 4 10 137
Sigma Convergence versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 0 1 0 1 10 30
Sigma Convergence versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 0 151 0 0 15 545
Sigma-Convergence Versus Beta-Convergence: Evidence from U.S. County-Level Data 0 0 0 522 0 6 13 1,676
Stronger IPR, Better Inclusion? Impact Of WTO Accession On Female AI Inventors in China 0 0 2 14 1 1 13 50
The Direct and Indirect Effects of Small Business Administration Lending on Growth: Evidence from U.S. County-Level Data 0 0 0 46 1 4 16 126
The Direct and Indirect Effects of Small Business Administration Lending on Growth: Evidence from U.S. County-Level Data 0 0 0 56 0 6 14 168
The Effect of Contractual Complexity on Technology Sourcing Agreements 0 0 0 40 2 5 8 268
The Impact of Patenting on New Product Introductions in the Pharmaceutical Industry 0 0 0 120 1 3 11 403
The Role of Assets In Place: Loss of Market Exclusivity and Investment 0 0 0 11 1 3 16 52
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling 0 0 0 14 0 3 10 59
Why Investment‑Led Growth Lowers Chinese Living Standards 0 1 4 19 1 8 30 43
Will Peak Demand Roil Global Oil Markets? 0 0 1 4 0 1 10 11
Total Working Papers 2 4 45 3,025 22 140 751 14,622


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Accounting for price endogeneity in airline itinerary choice models: An application to Continental U.S. markets 2 2 5 12 3 6 23 96
Behind the Scenes: Sources of Complementarity in R&D 0 0 0 6 0 6 24 77
Conveying quality and value in emerging industries: Star scientists and the role of signals in biotechnology 0 0 0 24 0 5 26 182
Corporate venture capital as a real option in the markets for technology 0 0 0 6 2 7 29 73
Evaluating the effects of Small Business Administration lending on growth 1 1 5 17 1 8 32 99
Federal, State, and Local Governments: Evaluating Their Separate Roles in US Growth 0 0 0 2 0 1 15 42
Federal, state, and local governments: evaluating their separate roles in US growth 0 0 0 32 0 1 14 195
Generic competition and the incentives for early-stage pharmaceutical innovation 0 0 3 7 1 5 23 39
Growth and Convergence across the United States: Evidence from County-Level Data 0 1 2 155 0 7 25 440
Growth and Convergence across the United States: Evidence from County-Level Data 0 0 0 4 1 1 12 42
Heterogeneous Convergence 0 0 0 3 0 4 19 49
Heterogeneous convergence 0 0 0 40 0 1 15 154
How Reliable Is the Market for Technology? 0 0 0 14 1 2 10 81
Modeling competition among airline itineraries 1 1 3 14 2 6 20 73
Pediatric Drug Adherence and Parental Attention: Evidence From Comprehensive Claims Data 0 0 0 0 0 0 7 7
Productivity and the role of complementary assets in firms' demand for technology innovations 0 0 0 23 1 5 17 126
Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry 0 0 0 11 0 7 12 86
Research and market structure: Evidence from an antibiotic-resistant pathogenic outbreak 0 0 0 0 0 3 17 21
Robust Correlates of County-Level Growth in the U.S 0 0 0 0 0 4 15 64
Robust correlates of county-level growth in the United States 0 0 0 11 0 1 5 56
Sigma Convergence versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 0 293 0 4 11 1,191
Sigma Convergence versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 1 11 0 9 28 68
Sigma Convergence versus Beta Convergence: Evidence from U.S. County‐Level Data 0 0 1 10 3 9 22 61
Strategic Alliances: Trading Ownership for Capabilities 0 0 0 8 0 3 15 55
The allocation of control rights in pharmaceutical alliances 0 0 0 60 0 1 3 168
The balance of payments crisis in the euro area periphery 0 0 2 180 1 4 28 723
The impact of advance purchase deadlines on airline consumers’ search and purchase behaviors 0 2 3 10 0 7 16 71
The outsourcing of R&D through acquisitions in the pharmaceutical industry 2 2 8 377 7 13 37 1,061
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling 0 0 1 4 0 8 14 33
Total Journal Articles 6 9 34 1,334 23 138 534 5,433


Statistics updated 2026-07-10